Clearside Biomedical, Inc.
CLSD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20 | $29 | $48 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $0 | $10 |
| Inventory | $0 | $0 | $0 | $1 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $21 | $30 | $49 | $42 |
| Property Plant & Equip (Net) | $4 | $4 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $4 | $4 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $25 | $34 | $51 | $43 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $4 | $3 |
| Total Curr. Liab. | $5 | $7 | $6 | $5 |
| LT Debt | $52 | $43 | $35 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $0 | $0 | $0 |
| Total NC Liab. | $59 | $43 | $35 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $64 | $50 | $41 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$355 | -$321 | -$288 | -$255 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $316 | $305 | $299 | $293 |
| Total Equity | -$39 | -$16 | $11 | $38 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $25 | $34 | $51 | $43 |
| Net Debt | $32 | $14 | -$13 | -$30 |